Sculptor Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Sculptor Capital’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,235,563	Closed	-$214M	–	536
2015 Q1	$214M	Buy	+1,235,563	New	+$181M	0.69%	52
2014 Q4	–	Sell	-626,147	Closed	-$97.8M	–	871
2014 Q3	$97.8M	Buy	+626,147	New	+$90.8M	0.28%	79

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Sculptor Capital's SLXP Position: Q2 2015 in Review

Sculptor Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,235,563 shares — an estimated $214M sold.

Sculptor Capital first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $214M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Sculptor Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Sculptor Capital sold 1,235,563 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $214M.
Sculptor Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
Sculptor Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $214M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Sculptor Capital's 13F filing for Q2 2015, filed 14 Aug 2015.